35th Annual Meeting ESACT-UK 2025
January 8 @ 11:00 am – January 9 @ 5:00 pm
The ESACT-UK 2024 Conference will be held in-person on the 8th and 9th January 2025 in Birmingham, UK. We will have Keynote speakers and multiple talks across sessions covering topics such as Advances in Immunotherapies, Big Data in Bioprocessing and Engineering Biology for Bioprocessing. We will also be showcasing the work of our early career researchers, followed by a panel session focussing on careers and skills. And of course, we will announce the winner of our annual CHRSA.
Further programme details and REGISTRATION
BioProNET2 – 11th Annual Science Meeting
GSK, Gunnels Wood Road, Stevenage. October 8th-9th 2024
REGISTRATION NOW CLOSED !
We have a packed and exciting programme to bring the sector together to engage with recent advances in our capability to make biological medicines with five scientific sessions, early career event, two dedicated poster sessions plus a chance to interact with our technology-provider exhibitors.
Great speakers, fascinating topics, visions of developing research themes, opportunities for early-career talks and posters ..…… join us and participate, network and learn.
Link to poster titles and short talks
Confirmed speakers include –
Kevin Vela (Cell and Gene Therapy Catapult) | David James (University of Sheffield) | Vassilis Paraskevas (Orchard Therapeutics) | Sarah Dunn (AstraZeneca, UK) | Zahra Rattray (University of Strathclyde) | Christoph Herwig (University of Ghent) | Tom Ellis (Imperial College London) \ Katrien Claes (VIB, University of Ghent) \ Miguel Pupo (DataHow, Switzerland) \ Mark Cunningham (Nucleic Acid Therapy Accelerator (NATA) \ Rob Field (University of Manchester)R
FULL PROGRAMME
.
.
.
Bioprocessing Entrepreneurial Skills Training (BEST) Programme
September 8th – 13th 2024, Durham.
Do you want to find out how your career might develop working for industry, the differences between industrial- and academic-driven research and how the industrial environment matches your career ambitions?
Are you interested? If you are (a) an Early Career Researcher (normally at year 3 or later of PhD training or on your first post-doctoral position in an academic environment but potentially in the early stages of an industrial career) and (b) working in the area of bioprocessing of biopharmaceuticals or novel biological therapeutics then this could be an ideal opportunity for you. It is likely that you are already working on a project that has an industrial collaborator but this is not essential.
The week-long residential programme is co-organised by BioProNET2 and E3B (a BBSRC Network in Industrial Biotechnology and Bioenergy, BBSRC NIBB) and is possible due to funding from the BBSRC. Participation will be limited to 18 attendees. Your accommodation, meals and all training activities will be provided to eligible applicants. Each participant will be asked to make a £150 non-returnable contribution for registration once their acceptance of a place is confirmed.
Formal REGISTRATION is now CLOSED and you can still make informal enquiries to Dr Jo Flannelly (joanne.flannelly@manchester.ac.uk).
Sessions form part of an integrated package that culminate in a Dragons Den-type pitch for establishment of a novel business concept:
-
Talks on molecular design for development, manufacture and delivery of biological therapeutics and the societal/economic consideration of novel therapeutics
-
Tutoring on the tools for self-awareness in working with others, career development and the entrepreneurial process
-
Industrial site visits (CPI, FUJIFILM Diosynth Biotechnologies, Iksuda Therapeutics) coupled with presentations from, and discussions with, industrial practitioners.
.
.
.
.
.
.
.
Welcome to BioProNET2 – Academic – Industry Network
BioProNET has evolved and returned as BioProNET2, an academic-industry networking club with sponsorship through a group of industrial and commercial colleagues who together with a group of academics (see below) aim to maintain and develop the community that was brought together so successfully by BioProNET. Our general objectives are to:
- mobilise a collaborative UK scientific community to address the challenges around, and enhance, the manufacture of emerging novel biological modalities.
- capitalise on entrepreneurship and address fundamental scientific challenges to enable robust and economically viable manufacture.
- develop a forum to engage academics and early career researchers with the industrial sector and entrepreneurial practitioners to provide a framework to train and inspire the next generation.
As a starting point for the focus of BioProNET2 we will be running an annual scientific meeting and a series of subject-specific workshops throughout each year, which this year will have a virtual, on-line structure. You have previously been associated with, and/or attended, meetings organised by BioProNET and, at this stage, we wish to inform you of our general plans and ask you to indicate your interest in hearing about, and being involved in, future activities organised by BioProNET2. We hope that you will and would ask you to forward this communication to any colleagues who you would also think would be interested in being part of BioProNET2 activities.
We are currently updating our BioProNET2 website so please check HERE and our Twitter feed for further information or please contact Jo Flannelly
BioProNET2 Steering Group:
Paul Dalby (UCL), Alan Dickson (University of Manchester), Jo Flannelly (University of Manchester), Cleo Kontoravdi (Imperial College), Mark Smales (University of Kent).
Current industrialists include representatives of Allergan Biologics, AZ, Cell & Gene Therapy Catapult, Fujifilm Diosynth Biotechnologies, GSK, Lonza Biologics, Pall Corporation.
Successes
Case studies of how our funding and events has brought together members from academia and industry to work on innovative research can be found here.
Read our interim achievement report
Member Profiles – read how BioProNET has helped members Charlie and Michael.
Newsletters & reports
Read our latest newsletter here.
Click here to read the BioProNET interim report – highlighting many of our achievements.
Photos from BioProNET’s 2017 Science Meeting, taken by Linas Tamosaitis
